Ultimately, the goals of the remote patient monitoring solution are to …
Medical devices create massive amounts of data, but it’s only been relatively recently that this information has been effectively harnessed to improve patient outcomes and experiences…
U.S. companies raised more than $8 billion for digital health last year. But investors injected just $986 million into 61 digital health deals in the first quarter of 2019 — about half of the money raised in Q1 2018, according to a funding report from Rock Health.
New York-based Mount Sinai Health System and the Hasso Plattner Institute, a German information technology institute that has bachelor’s and master’s degree programs, have teamed up to launch a new digital health institute, according to a news release sent to MedCity.
The Aktiia PulseWatch optical blood pressure monitor was tested in six healthy volunteers and agreed with a traditional inflating-cuff blood pressure monitor (Omron M6) two months after the initial calibration. The PulseWatch was accurate to within 1 ± 7 mmHg, which satisfied the 5±8 mmHg guidelines set by the AAMI (Association for the Advancement of Medical Instrumentation).
As MD+DI has previously reported, artificial intelligence is playing an increasingly significant role in medical devices. Now, a new study from the United Kingdom suggests that AI could be used to predict premature death. The findings could have major implications for preventative healthcare, according to researchers at the University of Nottingham.
“Despite all the advances in digital health and how technology is applied in healthcare, the daily life for a person with a chronic condition hasn’t improved much at all in the past few decades,” said Livongo Chief Product Officer Amar Kendale in an interview with MD+DI.
Brian Harris is a board-certified music therapist. His work took him to Spaulding Rehabilitation Hospital in Boston, where he started the organization’s first Neurologic Music Therapy program. Harris was utilizing music to help patients improve their ability to walk, and it was working.
New light is being shed on the effectiveness of wearable technology to detect atrial fibrillation (Afib) thanks to preliminary results from a new study by Stanford University School of Medicine researchers and Apple.
Apple (NSDQ:AAPL) today released data from its 419,297-patient Apple Heart Study, showing that the device is capable of aiding in the detection of atrial fibrillation using its light-sensor based technology.
Connectivity has changed how a patient is diagnosed, treated, and managed. Yet in this digital world, each connectivity point introduces a potential weakness that a growing number of attackers may try to exploit. Who should take the lead on Cyber-security measures?
Globally, more than 325 million people own wearable, connected devices, and more than 2.5 billion own smartphones. Using wearable devices in clinical trials can bring huge benefits, however, there are also concerns.
As leading companies in the nascent digital therapeutics industry work to gain regulatory approval and adoption of their products one pathway to commercialization has been through partnerships with pharmaceutical companies.
In the face of competition in the wearables space from the likes of Samsung and Apple, San Francisco-based wearables pioneer Fitbit has responded through new lower-cost consumer devices and increasing focus on its enterprise business lines as it moves past basic fitness tracking capabilities.